Search results
-
Media hub
Explore the latest news, blogs, and media from Croda on our innovative ingredients, sustainability achievements, and global collaborations.
-
Media coverage Page Summary Title
Media coverage Page Summary Description
-
Supporting Invisible Disabilities Week at Croda
Learn how Croda supports Invisible Disabilities Week, promoting awareness and inclusivity for employees with hidden disabilities. Discover personal stories, like Sana Bell’s, and our commitment to creating a supportive workplace for everyone to thrive.
-
Croda launches animated timeline to showcase 100 years of innovation
13 February 2025: Croda today launches an animated historical timeline to mark its centenary year.
-
USA
Croda Inc is the North American headquarters for Croda, with over 800 employees, working in a variety of roles in manufacturing, sales, marketing and research and development.
-
Our markets
We provide innovative ingredients and develop solutions for customers that enhance the performance of their products and help them to differentiate their brands.
-
Our centenary
2025 is Croda’s centenary year which provides an excellent opportunity to celebrate our rich history and reflect on the strong foundations it gives us for future success.
-
North America
Croda Inc is the North American headquarters for Croda, we have four manufacturing sites, four innovation centres and four sales hubs in the region.
-
Navigating the future of innovative ingredients
As Croda celebrates 100 years of delivering Smart science to improve lives™, we’re also looking ahead. This Vision Report is a forward-looking guide to the trends that will reshape the speciality ingredients industry across the next quarter-century.
-
Diversity and inclusion
In 2021 we defined a D&I roadmap identifying actions, regarding diversity and inclusion, in five key areas.
-
100 years of smart science: Celebrating Croda's centenary at our headquarters
Join us as we celebrate Croda’s 100-year journey from a small family firm in Yorkshire to a global leader in sustainable innovation. Discover the science, stories, and people behind a century of improving lives.
-
Customer driven
We are listening more closely to our customers than ever before; understanding the things that are of most importance to our customers and how we are performing against them.
-
Acts of kindness
The Croda Acts of Kindness programme gave employees the opportunity to nominate local causes and charities to support during COVID-19, with each major site given £10,000.
-
Flue2Chem
In another example of industry-wide collaboration to help tackle the climate emergency, the Flue2Chem Innovate UK project aims to demonstrate that a UK supply chain to produce alkoxylated surfacants from CO2 is economically and technically feasible.
-
Digitalisation in manufacturing
We can see the potential of big data, robotics, analytics and the Internet of Things to drive manufacturing excellence and contribute to our right first time agenda.
-
Leveraging expertise in UV filters for Asian markets
There are over three million cases of skin cancer globally each year, responsible for tens of thousands of deaths. Our range of sunscreens meets a clear need and is an important pillar of our sustainability Commitment to be People Positive by 2030.
-
Human Performance programme
Our behavioural safety improvement programmes were standardised into a Group-wide Behavioural Safety Observation programme, implemented across all manufacturing sites since 2015.
-
Reforestation
Revitalising ecosystems, improving biodiversity and creating social and economic benefits for local communities.
-
1.5°C science-based target validation
In July 2021 we became only the third major chemical company globally to have a 1.5ºC science-based target validated.
-
Investor overview
Croda is a successful global company with 105 operations across 39 countries, a focused Life Sciences and Consumer Care company.
-
Responsible business
/Images/Corporate/Corporate V2/Sustainability/Our commitment sustainability image
-
Coltide Radiance sustainability in use
In October we were delighted that our sustainability leadership was recognised as we won Business of the Year at the World Sustainability Awards.
-
Share price
Detailed share charts.
-
Waste management
Iberchem, our global fragrance and flavours business based in Spain, has championed waste management best practices through robust policies and employee education programmes.
-
Agroforestry in the Amazon
The Croda Foundation is supporting an Instituto Amazonas agroforestry project, which aims to revive traditional agriculture practices among indigenous tribes, improving food security and protecting their cultural heritage and environment.
-
Shareholder centre
Useful information for Croda Shareholders.
-
Supplying delivery systems to help prevent cardiovascular disease
Nucleic acid-based therapies are the next big blockbuster drug class opening up exciting applications such as gene editing, where a patient’s genetic material can be modified to correct a disorder.
-
Supporting the next generation of therapeutic vaccines
Vaccine adjuvants are used to enhance immune response to an antigen, improving the overall efficacy of the vaccine and increasing protection against the target disease.
-
Bringing anti-ageing benefits to make-up
Developed through one of our Smart Partnerships, Majestem® Drypure™ from our beauty actives business, Sederma, brings anti-ageing and environmental protection benefits to make-up.
-
Sustainability-linked revolving credit facility
In 2019, we became one of the UK’s first large public companies to include a sustainability metric in a revolving credit facility (RCF), with targets in the seven-year agreement aligned with our 2030 Commitment to become Climate Positive.
-
Collaboration to develop alternative vaccine adjuvants
In 2021 we established a strategic collaboration with the Danish Government’s life science research institute, Statens Serum Institute (SSI).
-
Investors
Investor information including financial reporting and events.
-
Finance review 2025
“With a comprehensive transformation programme that is driving both growth and efficiencies, we are firmly focused on execution. Progress so far has been encouraging, and we are setting out a financial framework to full year 2028 that outlines further improvements in financial performance.”
-
Life Sciences business review - rebalancing Pharma and driving differentiation in Agriculture
Discover how Life Sciences is rebalancing Pharma and driving differentiation in Agriculture. Exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.
-
Industrial Specialties business review
Discover how Industrial Specialties is enabling continued growth, exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.
-
Consumer Care business review
Discover how Consumer Care is reinvigorating Beauty and enabling continued growth in Fragrances & Flavours. Exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.
-
Croda unveils Matrixyl® Neolide™, an iconic peptide with smarter delivery
Croda introduces Matrixyl® Neolide™, an iconic peptide with smarter delivery, designed to maximise performance and unlock new possibilities in advanced skin care.
-
Investor seminar on our Life Sciences sector
7 October 2019: Senior members of our management team provided a comprehensive overview of the Life Sciences sector, with a particular focus on our Health Care business.
-
Site visit to Sederma Beauty Actives business in France
17-18 March 2016: Croda International plc hosted a Capital Markets Event for analysts and investors at its Sederma facility near Versailles, France.
-
Chairs statement 2025
A message from the Chair, Danuta Gray, highlighting the company’s performance, strategic progress, governance priorities, and outlook for sustainable growth in the year ahead.
-
Chief Executive's Statement 2025
An overview from Steve Foots, our Chief Executive, outlining the year’s key achievements, business performance, strategic priorities, and future outlook for growth and innovation.
-
Advancing the efficacy and impact of vaccines
The acquisition of Biosector in 2018 strengthened our pharmaceutical offering, taking us into the field of vaccine adjuvants.
-
Abiotic stress mitigation in onions
Changing climates mean higher temperatures, periods of drought and higher salinity are becoming an increasing problem for farmers.
-
Net zero roadmap for UK manufacturing site
We became one of the first UK manufacturing sites to develop a 2050 net zero roadmap as part of the UK Government’s Department for Business, Energy and Industrial Strategy ‘Industry of the Future’ programme.
-
Advocating for Access and Benefit Sharing and biodiversity conservation
We supported the launch of the third edition of the Brogota Project through the United Nations Biodiversity Conference COP15 side event.
-
Improving performance by humanising safety
Involvement and engagement have increased, and longstanding infrastructure and operational issues are being addressed following a pilot Human Performance Programme at our site in Thane, India.
-
Launch of first report on biotechnology opportunities in the personal care market
27 September 2022: The “Biotechnology: personal care market report” is the first in a series from Croda which aim to help other forward-thinking companies leverage the opportunities offered by biotechnology.
-
Transition to bio-based MPG
Transitioning our raw materials to bio-based sources will enable us to make a significant positive impact.
-
Life cycle assesment
Supporting our customers to realise the benefits of LCA meant that in 2022 we began developing our LCA Centre of Excellence, supporting sectors in examining the risks and benefits of their portfolios.
-
Uni of Cambridge case study
Working with technology designers NiTech Solutions and The University of Cambridge’s Institute for Manufacturing, we created a new process to manufacture more sustainable surfactants. Traditionally, industrial production of surfactants often occurs in large batch reactors, which have low energy efficiency and a long reaction time.